Compare CVS Health Corp (CVS) vs J M Smucker Co (SJM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs J M Smucker Co — how do they compare? CVS Health Corp trades at $86.82 (market cap $112.49B), while J M Smucker Co trades at $120.56 (market cap $12.38B). The key difference: CVS Health Corp is far larger — about 9.1× J M Smucker Co's market cap, and J M Smucker Co pays the higher dividend (3.86%). Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and J M Smucker Co for 74 Days on average.
| CVS | SJM | |
|---|---|---|
Market Cap | $112.49B | $12.38B |
Volume | 8,467,392 | 1,013,558 |
Sector | Health | Consumer Staples |
52-Week High | $110.60 | $132.34 |
52-Week Low | $70.08 | $89.53 |
Typical Hold Time | 83 Days | 74 Days |
Enterprise Value | $174.83B | $19.24B |
Dividend Yield | 3.02% | 3.86% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $87.95, up 1.76% with strong analyst support (85% buy ratings) and a $111.20 consensus price target suggesting 26% upside. Recent quarterly earnings consistently beat expectations, with Q2 2026 EPS of $2.58 surpassing the $1.85 estimate. Revenue growth remains solid at $402.07 billion for 2025, though net margins compressed to 1.18%. Technical indicators show a bullish overall signal with support at $87 and resistance at $89.
The outlook remains positive given CVS's dominant market position and Medicare expansion plans, but investors face risks from reimbursement pressures and ongoing legal investigations. Earnings growth and successful execution of healthcare services integration represent the primary catalysts for continued stock appreciation.
SJM trades at $119.41, up 2.23% today, with a bearish technical signal but strong recent earnings beats. The company reported a net loss of $1.23 billion in 2025 despite revenue growth to $8.73 billion, though analysts project a return to profitability in 2026. A dividend of $1.12 is scheduled for September 2026, and institutional interest is rising, as seen with CalSTRS increasing its stake significantly in Q2 2026.
The outlook is mixed: analyst consensus is bullish with a $137.29 price target, but high debt and volatile profitability pose risks. Earnings momentum from recent beats and raised 2027 guidance support upside, yet investors must weigh margin pressures and competitive threats in the consumer staples sector against growth in segments like Uncrustables and Cafe Bustelo.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About J M Smucker Co
J.M. Smucker is a packaged food company that primarily operates in the U.S. retail channel (87% of fiscal 2022 revenue), but also in U.S. food-service (7%), and international (6%). Its largest segment is pet food and treats (36% of 2022 revenue), with popular brands such as Milk-Bone, Meow Mix, 9Lives, Kibbles 'n Bits, Nature's Recipe, and Rachael Ray Nutrish. Its second-largest category is coffee (35% across channels) with the number-two brand Folgers and number-six Dunkin'. Other large categories are peanut butter (10%), with number-one Jif, fruit spreads (5%) with number-one Smucker's, and frozen hand-held foods (6%) with number-one Uncrustables.
Read more on SJM →
